packagePertuzumab

pertuzumab

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Pertuzumab is a monoclonal antibody that blocks HER2 and is used to treat breast cancer. It is an approved medicine, authorised in the European Union for breast cancer, and is also being studied for other uses.

Summary written by glm-5.3-flash from Wikidata Q1998021 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:pertuzumab
ATC codes:L01FD02
DrugBank:DB06366
Wikidata:Q1998021
molar mass:148000 g/mol (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown